YI
NASD 111, Inc. Sponsored ADR$3.09 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.09, $0.16 below the day’s high of $3.25
- YTD change
- +20.70%
- vs 20-day SMA
- -10.56%
- vs 200-day SMA
- -39.16%
Price ranges
Price & Performance
-3.13 (-50.32%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.3% away from all-time highs of $458.80
- YI is up 21% since the beginning of the year
- YI is down 32% over the past 12 months
- YI is down 11% over the past 1 month
- 0% of all YI investors are betting against YI
YI reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -34.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -12.22%
- vs 8-day SMA
- -9.48%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
